PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Clinical trials for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could your DNA predict lung blood pressure disease?
Knowledge-focused Recruiting nowThis study aims to find genetic factors linked to pulmonary hypertension (high blood pressure in the lungs). Researchers will collect health surveys and saliva samples from 10,000 US adults aged 18 and older, both with and without the condition. Participation is online and takes …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated May 26, 2026 05:38 UTC
-
PAH drug switch under the microscope: will patients fare better?
Knowledge-focused Recruiting nowThis study looks at what happens when people with pulmonary arterial hypertension (PAH) switch from one medication (ambrisentan) to another (bosentan). Researchers will track 121 adults over 3-6 months to see if their risk scores, symptoms, and lab results change. The goal is to …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Sponsor: University of Sao Paulo General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 05:31 UTC
-
New tool aims to gauge PAH patient knowledge
Knowledge-focused Recruiting nowThis study is creating and testing a questionnaire to see how much people with pulmonary arterial hypertension (PAH) know about their disease. Researchers will check if the questions make sense to patients and experts, and if the tool gives reliable results. Up to 200 adults with…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Phase: NA • Sponsor: University of Sao Paulo General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 05:30 UTC
-
Why does it take so long to diagnose this rare lung disease?
Knowledge-focused Recruiting nowThis study aims to understand why diagnosing pulmonary arterial hypertension (PAH), a rare and serious lung disease, often takes a long time. Researchers will review medical records from 139 adults in Brazil to track how long symptoms go unnoticed and how many doctors are seen be…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Sponsor: University of Sao Paulo General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 05:29 UTC